These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3526191)

  • 1. [Echotomographic, colonoscopic and clinical evaluation of syntropium bromide].
    Vinciguerra V; Doronzo F; Tardi S; Vasti MT; Cecere O; Baldassarre G; Palasciano G; Biraghi M
    Minerva Dietol Gastroenterol; 1986; 32(2):197-201. PubMed ID: 3526191
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sintropium bromide (VAL 480): a new spasmolytic agent in general surgery].
    Bianchi M; Casetti M; Pulvirenti A; Biraghi M
    Minerva Chir; 1986 Oct; 41(19):1661-4. PubMed ID: 3808371
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of sintropium bromide, a new spasmolytic, in obstetrics and gynecology].
    Maritati V; Tanganelli E; Boccardo E; Camandona F; Pietrasanta R; Maganza C; Monti G
    Minerva Ginecol; 1986 Nov; 38(11):965-9. PubMed ID: 3808432
    [No Abstract]   [Full Text] [Related]  

  • 4. [Instrumental and clinical evaluation of syntropium bromide (VAL 480), a new synthetic spasmolytic].
    Norberto L; Sandei F; Monti G
    Minerva Dietol Gastroenterol; 1986; 32(2):203-7. PubMed ID: 3526192
    [No Abstract]   [Full Text] [Related]  

  • 5. [Colic and spastic states of the urinary tract. Comparison between syntropium bromide (VAL 480) with ioscine n-butylbromide and with noramidopyrine-pitofenone-fenpiverinium bromide].
    Colpi GM; Politi P; Sandri S; Fanciullacci F; Biraghi M; Zanollo A
    Minerva Urol Nefrol; 1985; 37(3):341-8. PubMed ID: 3911456
    [No Abstract]   [Full Text] [Related]  

  • 6. Cystometric evaluation of the activity of a new spasmolytic agent - rociverine.
    Manganelli A
    Farmaco Prat; 1979 Sep; 34(9):384-92. PubMed ID: 553816
    [No Abstract]   [Full Text] [Related]  

  • 7. Rociverine compared with other spasmolytics for cardiovascular effects.
    Guelfi M; Schiantarelli P; Subissi A
    Farmaco Prat; 1981 Aug; 36(8):374-82. PubMed ID: 7274417
    [No Abstract]   [Full Text] [Related]  

  • 8. [The use of syntropium bromide as an antispasmodic].
    Galeone M; Cacioli D; Moise G; Bossi M; Benazzi E; Monti G
    Minerva Med; 1985 Sep; 76(36):1605-10. PubMed ID: 3900811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticoagulant and antiatherosclerotic effects of 1-ethoxysilatrane].
    Rasulov MM; Kuznetsov IG; Velikaia MV; Bartkova LK; Voronkov MG
    Dokl Akad Nauk SSSR; 1990; 310(5):1256-9. PubMed ID: 2354655
    [No Abstract]   [Full Text] [Related]  

  • 10. [The mechanism of membranotropic action of 1-ethoxysilatrane].
    Rasulov MM; Kuznetsov IG; Belousov AA; Voronkov MG
    Dokl Akad Nauk SSSR; 1989; 306(6):1479-82. PubMed ID: 2553369
    [No Abstract]   [Full Text] [Related]  

  • 11. Further studies into the ECG effects of tedisamil (KC 8857) in rats.
    Howard PG; Abraham S; Courtice ID; Walker MJ
    Proc West Pharmacol Soc; 1989; 32():183. PubMed ID: 2780585
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of potent analgesic 3-(beta-phenylethyl)-9 beta-methoxy-9 alpha-(m-hydroxyphenyl)-3-azabicyclo [3,3,1]-nonane (p-5721) on electroencephalography in rabbits].
    Zhao GM; Zhou J; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1988 Jul; 9(4):300-3. PubMed ID: 3195338
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methylethyl(silatran-1-ylmethyl)sulfonium iodide--an inhibitor of the development of experimental atherosclerosis of the aorta].
    Rasulov MM; Kuznetsov IG; Sorokin MS; Voronkov MG
    Dokl Akad Nauk SSSR; 1989; 304(2):474-6. PubMed ID: 2731468
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of the long-acting analgesics 3-(beta-phenylethyl)-9 beta-methoxy-9 alpha-(m-hydroxyphenyl)-3-azabicycles [3,3,1]-nonane (P-7521) on opiate receptor binding in vitro].
    Zhou DH; Ge BL; Xu XJ; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1988 Nov; 9(6):511-5. PubMed ID: 2855686
    [No Abstract]   [Full Text] [Related]  

  • 15. [Analgesic activity and respiratory inhibition of 3-beta-phenylethyl)-9 beta-methoxy-9 alpha-(m-hydroxyphenyl)-3-azabicyclo [3,3,1]-nonane (P-7521) in rabbits].
    Zhou J; Zheng WJ; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1987 Jan; 8(1):10-3. PubMed ID: 2955652
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of haemorrhage on wound healing and its possible modification by 1-ethoxysilatrane.
    Taylor DE; Cooper GJ; Evans VA; Kenward CE; Lawston IW; Penhallow JE; Whamond JS
    J R Coll Surg Edinb; 1986 Feb; 31(1):13-7. PubMed ID: 2940364
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of isopropoxysilatrane and isopropoxygermatrane on connective tissue proliferative and reparative function].
    Mansurova LA; Voronkov MG; Slutskiĭ LI; Bumagina TP; Gar TK
    Dokl Akad Nauk SSSR; 1982; 262(6):1505-6. PubMed ID: 7067613
    [No Abstract]   [Full Text] [Related]  

  • 18. KC 9172 (free base of KC 7218)--an antipsychotic/anxiolytic compound. I. Antipsychotic and anxiolytic activity in comparison with chlorpromazine, clozapine, diazepam and buspirone.
    Ruhland M; Krähling H; Fuchs A; Schön U
    Pharmacopsychiatry; 1988 Nov; 21(6):396-8. PubMed ID: 2907649
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mechanism of membranotropic effect of methylethyl(silatrane-1-yl methyl) sulfonium iodide].
    Kuznetsov IG; Rasulov MM; Sorokin MS; Suslova SK; Voronkov MG
    Dokl Akad Nauk SSSR; 1988; 301(5):1235-7. PubMed ID: 2852585
    [No Abstract]   [Full Text] [Related]  

  • 20. [The anticoagulant and antisclerotic effects of isopropoxygermatrane and methylethyl(silatrane-1-ylmethyl)sulfonium iodide].
    Rasulov MM; Kuznetsov IG; Velikaia MV; Kaplan BS; Voronkov MG
    Biull Eksp Biol Med; 1989 Dec; 108(12):692-4. PubMed ID: 2634441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.